Children with rheumatic diseases may face increased risks for COVID-19-related hospitalization, particularly those using glucocorticoids, rituximab, or mycophenolate.
India's first heart failure registry reveals younger patients, high mortality rates, and varying causes of heart failure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback